Resazurin Sodium Salt: Mechanistic Innovation and Strateg...
2025-10-17
This thought-leadership article presents a comprehensive, mechanistically rich, and strategically actionable perspective on the use of Resazurin sodium salt as a fluorogenic oxidation-reduction indicator in translational research. Integrating recent advances from disease modeling, including cystic fibrosis drug development, and competitive assay landscapes, we deliver evidence-based guidance and a visionary outlook for researchers seeking robust, scalable, and clinically relevant cell viability solutions.